BR112021017625A2 - Peptídeo inovador e uso do mesmo - Google Patents

Peptídeo inovador e uso do mesmo

Info

Publication number
BR112021017625A2
BR112021017625A2 BR112021017625A BR112021017625A BR112021017625A2 BR 112021017625 A2 BR112021017625 A2 BR 112021017625A2 BR 112021017625 A BR112021017625 A BR 112021017625A BR 112021017625 A BR112021017625 A BR 112021017625A BR 112021017625 A2 BR112021017625 A2 BR 112021017625A2
Authority
BR
Brazil
Prior art keywords
present
peptide
innovative
effectively treating
preventing
Prior art date
Application number
BR112021017625A
Other languages
English (en)
Inventor
Eun-Joung Moon
Jin Kim Hae
Hoon Lee Young
Original Assignee
Ensol Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ensol Biosciences Inc filed Critical Ensol Biosciences Inc
Publication of BR112021017625A2 publication Critical patent/BR112021017625A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)

Abstract

peptídeo inovador e uso do mesmo. a presente invenção se refere a um peptídeo que consiste na sequência de aminoácidos de seq id no:1 ou um sal farmaceuticamente aceitável do mesmo e ao uso do mesmo. a presente invenção é capaz de tratar ou prevenir eficazmente a insulite. além disso, a presente invenção é capaz de tratar ou prevenir eficazmente o diabetes tipo 1.
BR112021017625A 2019-03-13 2020-03-05 Peptídeo inovador e uso do mesmo BR112021017625A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020190028654A KR101995768B1 (ko) 2019-03-13 2019-03-13 신규 펩타이드 및 그 용도
PCT/KR2020/003132 WO2020184901A1 (en) 2019-03-13 2020-03-05 Novel peptide and use thereof

Publications (1)

Publication Number Publication Date
BR112021017625A2 true BR112021017625A2 (pt) 2021-11-09

Family

ID=67258723

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021017625A BR112021017625A2 (pt) 2019-03-13 2020-03-05 Peptídeo inovador e uso do mesmo

Country Status (10)

Country Link
US (1) US20220135621A1 (pt)
EP (1) EP3938376A4 (pt)
JP (1) JP7163547B2 (pt)
KR (1) KR101995768B1 (pt)
CN (1) CN113508126B (pt)
AU (1) AU2020234373B9 (pt)
BR (1) BR112021017625A2 (pt)
CA (1) CA3132808A1 (pt)
MX (1) MX2021010552A (pt)
WO (1) WO2020184901A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101995768B1 (ko) * 2019-03-13 2019-07-03 (주)엔솔바이오사이언스 신규 펩타이드 및 그 용도
KR102624902B1 (ko) * 2023-08-24 2024-01-17 주식회사 엔솔바이오사이언스 노나펩타이드의 신규 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2709839B2 (ja) * 1987-12-25 1998-02-04 三井東圧化学株式会社 膵疾患等の予防・治療剤
KR20010081515A (ko) * 2000-02-15 2001-08-29 복성해 프로디지오신의 당뇨병 예방 및 치료용 조성물
CA2404825A1 (en) * 2000-03-24 2001-09-27 Japan As Represented By President Of Tokyo University Of Agriculture Andtechnology Precursors of silk-like materials, silk-like materials and processes for producing both
US20100256061A1 (en) * 2007-03-02 2010-10-07 Antonio Cruz Gastrin compound for diabetes treatment
EP2193142B1 (en) * 2007-08-30 2015-01-07 CureDM Group Holdings, LLC Compositions and methods of using proislet peptides and analogs thereof
KR100983182B1 (ko) * 2009-08-14 2010-09-20 (주)엔솔테크 신규 펩타이드 및 그 용도
KR101029705B1 (ko) * 2010-06-30 2011-04-18 (주)엔솔테크 신규 펩타이드 및 그 용도
EP2956475A4 (en) * 2013-02-15 2016-11-16 Univ Mcgill MODIFIED INGAP PEPTIDES FOR THE TREATMENT OF DIABETES
US20160200789A1 (en) * 2013-04-26 2016-07-14 Philogen S.P.A. Il4 conjugated to antibodies against extracellular matrix components
CN104059131A (zh) * 2014-07-04 2014-09-24 丝科普乐（北京）生物科技有限公司 抗丝素蛋白多克隆抗体及其制备方法
KR101644982B1 (ko) * 2015-07-23 2016-08-02 주식회사 엔솔바이오사이언스 신규 펩타이드 및 그 용도
KR101909052B1 (ko) * 2017-02-09 2018-10-17 강원대학교산학협력단 인슐린의 a 사슬로부터 유래된 펩타이드 단편 및 이를 포함하는 당뇨병 또는 당뇨병성 창상의 예방 또는 치료용 약학 조성물
KR101995768B1 (ko) * 2019-03-13 2019-07-03 (주)엔솔바이오사이언스 신규 펩타이드 및 그 용도

Also Published As

Publication number Publication date
MX2021010552A (es) 2021-10-01
KR101995768B1 (ko) 2019-07-03
JP2022524585A (ja) 2022-05-09
CN113508126B (zh) 2023-09-29
AU2020234373A9 (en) 2021-10-14
AU2020234373B2 (en) 2022-05-12
WO2020184901A1 (en) 2020-09-17
CA3132808A1 (en) 2020-09-17
AU2020234373A1 (en) 2021-09-30
EP3938376A4 (en) 2023-03-29
EP3938376A1 (en) 2022-01-19
US20220135621A1 (en) 2022-05-05
JP7163547B2 (ja) 2022-11-01
AU2020234373B9 (en) 2022-06-23
CN113508126A (zh) 2021-10-15

Similar Documents

Publication Publication Date Title
BR112021017625A2 (pt) Peptídeo inovador e uso do mesmo
BRPI1010120A2 (pt) composição de surfactante reconstituído melhorada contendo análogos de proteína b do surfactante (sp-b) e proteína c do surfactante ( sp-c)
RU2011106744A (ru) Инсулин, стабилизированный галогеном
BRPI0409624A (pt) 2-hidróxi-3-diaminoalcanos de benzamida
BR112018076693A2 (pt) análogos de urocortina-2 modificados por ácido graxo, para o tratamento de diabetes e doença renal crônica
BR0211118A (pt) Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal
BR0212787A (pt) Composto ou sal farmaceuticamente aceitável do mesmo, métodos de tratamento ou prevenção de doenças e de preparação de um composto, uso de um composto ou sal, e, composição farmacêutica
BR112012031587A2 (pt) novo peptídeo e uso do mesmo.
BR112019005246A2 (pt) composto com a fórmula i, composto com a fórmula ii, composto com a fórmula iii, composição farmacêutica, método de tratamento de câncer
NZ756128A (en) Novel peptides and analogs for use in the treatment of oral mucositis
BR112013032088A2 (pt) "polipeptídeo, composição farmacêutica e seu uso"
BR112013025975A2 (pt) proteína de fusão anticancerígena
BR112022012470A2 (pt) Proteína rsv f mutante e uso da mesma
BR112023006761A2 (pt) Compostos de peptídeo curto de prolina modificado no anel, composição farmacêutica e uso dos mesmos
WO2010151495A3 (en) Materials and methods for treating and preventing viral infections
PH12020551118A1 (en) Modified lipidated relaxin b chain peptides and their therapeutic use
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
BR112018071214A2 (pt) peptídeo para uso no tratamento, melhora ou prevenção de osteoartrite
BR112018070819A2 (pt) peptídeos e composições farmacêuticas, nutracêuticas ou veterinárias para prevenção e/ou tratamento de queda de cabelo
UY33568A (es) Compuestos que interactuan con proteina reguladora de glucocinasa para el tratamiento de diabetes.
BR112023025789A2 (pt) Nitroxolina para uso no tratamento de neurofibroma cutâneo
BR112018071215A2 (pt) peptídeo para uso no tratamento, melhora ou prevenção de osteoartrite
BR112022016528A2 (pt) Anticorpo antiadrenomedulina (adm) ou fragmento de anticorpo anti-adm ou scaffold anti-adm não ig para uso em terapia ou prevenção de choque
AR061825A1 (es) Analogos del peptido intestinal vasoactivo (vip)
EA202090802A1 (ru) Пептидная композиция для лечения повреждений, связанных с возбуждающей нейротоксичностью